
Sign up to save your podcasts
Or
In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth Hougen, CFO of Ionis – a leading innovator in the development of antisense medicines and RNA-targeted therapeutics – to find out how the firm is embedding ESG into its vision, strategy and performance.
5
1212 ratings
In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth Hougen, CFO of Ionis – a leading innovator in the development of antisense medicines and RNA-targeted therapeutics – to find out how the firm is embedding ESG into its vision, strategy and performance.
81,748 Listeners
112,758 Listeners
56,140 Listeners
314 Listeners
57 Listeners
60 Listeners
84 Listeners
27 Listeners
39 Listeners
9 Listeners
10 Listeners
0 Listeners
1 Listeners
17 Listeners
76 Listeners
11 Listeners